This section contains further information for our shareholders.
Disclaimer
The information contained herein does not constitute an offer for sale or a solicitation for submission of an offer for purchase or subscription of shares and/or securities of any kind whatsoever in BioPharmcor BV and/or any of its affiliated companies including BioPharmcor Inc. It is provided solely as information.
Not investment advice
The information contained herein does not constitute investment advice.
Forward-looking statements
Insofar as forecasts, estimates, opinions or expectations are expressed or forward-looking statements are made in the information contained herein, these statements may involve known and unknown risks and uncertainties. The actual results and developments may therefore differ substantially from the expectations and assumptions expressed.
Risk investment
Investment in sector companies in the Healthcare and Pharmaceutical field can offer great opportunities but they inevitably involve correspondingly high risks. Investment in these companies should therefore, as a matter of principle, be classified as a risk investment. Loss of the sum invested cannot be ruled out. That is why this form of investment is in general better suited for diversification as part of a broader portfolio strategy.
Investor notice
ONLY INVESTORS WHO HAVE NOTED THE ABOVE CONDITIONS AND AGREE TO BE BOUND BY THEM ; AND INVESTORS WHO ARE NORMALLY RESIDENT OUTSIDE THE UNITED STATES OF AMERICA (USA) SHOULD CONTINUE WITH THE INFORMATION PROVIDED.
*Further company information BioPharmcor B.V.
|
Date of foundation RSIN Establishment number |
January 2015 854831150 000031474969 |
|
Accounting standard |
International Financial Reporting Standard (IFRS) |